Simons Colinda C J M, van den Brandt Piet A, Stehouwer Coen D A, van Engeland Manon, Weijenberg Matty P
Department of Epidemiology, GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
Department of Internal Medicine, CARIM - School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, the Netherlands.
Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1852-62. doi: 10.1158/1055-9965.EPI-13-1285. Epub 2014 Jun 27.
We investigated body size, physical activity, and early-life energy restriction in relation to colorectal tumors with and without methylated insulin-like growth factor-binding protein (IGFBP) genes, which are putative tumor-suppressor genes.
We determined IGFBP2, IGFBP3, and IGFBP7 promoter CpG island hypermethylation in tumors of 733 colorectal cancer cases from the Netherlands Cohort Study (N = 120,852). Participants self-reported lifestyle and dietary factors at baseline in 1986. Using a case-cohort approach (N subcohort = 5,000), we estimated hazard ratios (HR) for colorectal cancer by extent of IGFBP methylation.
Comparison of the highest versus lowest sex-specific tertiles of adult body mass index (BMI) gave multivariable-adjusted HRs [95% confidence intervals (CI)] for colorectal cancers with 0 (18.7%), 1 (29.5%), 2 (32.4%), and 3 (19.5%) methylated genes of 1.39 (0.88-2.19), 1.11 (0.77-1.62), 1.67 (1.17-2.38), and 2.07 (1.29-3.33), respectively. Other anthropometric measures and physical activity were not associated with colorectal cancer risk by extent of IGFBP methylation, except height in sex-specific analyses for women. Exposure to energy restriction during the Dutch Hunger Winter versus nonexposure gave HRs (95% CIs) for colorectal cancers with 0, 1, 2, and 3 methylated genes of 1.01 (0.67-1.53), 1.03 (0.74-1.44), 0.72 (0.52-0.99), and 0.50 (0.32-0.78), respectively.
Adult BMI, height (in women only), and early-life energy restriction were associated with the risk of having a colorectal tumor characterized by IGFBP methylation.
Body size may particularly increase the risk of IGFBP gene-methylated colorectal tumors; this finding might facilitate more targeted approaches to prevent obesity-related colorectal cancers.
我们研究了体型、身体活动以及生命早期的能量限制与伴有或不伴有甲基化胰岛素样生长因子结合蛋白(IGFBP)基因的结直肠肿瘤之间的关系,这些基因被认为是肿瘤抑制基因。
我们在荷兰队列研究(N = 120,852)的733例结直肠癌病例的肿瘤中测定了IGFBP2、IGFBP3和IGFBP7启动子CpG岛的高甲基化情况。参与者在1986年基线时自我报告了生活方式和饮食因素。采用病例队列研究方法(N亚队列 = 5000),我们根据IGFBP甲基化程度估计了结直肠癌的风险比(HR)。
将成年人体质量指数(BMI)的最高与最低性别特异性三分位数进行比较,对于甲基化基因数量为0(18.7%)、1(29.5%)、2(32.4%)和3(19.5%)的结直肠癌,多变量调整后的HR [95%置信区间(CI)]分别为1.39(0.88 - 2.19)、1.11(0.77 - 1.62)、1.67(1.17 - 2.38)和2.07(1.29 - 3.33)。除女性性别特异性分析中的身高外,其他人体测量指标和身体活动与结直肠癌风险之间不存在与IGFBP甲基化程度相关的联系。与未暴露于荷兰饥荒冬季期间的能量限制相比,暴露于此期间的能量限制对于甲基化基因数量为0、1、2和3的结直肠癌的HR(95% CI)分别为1.01(0.67 - 1.53)、1.03(0.74 - 1.44)、0.72(0.52 - 0.99)和0.50(0.32 - 0.78)。
成年BMI、身高(仅在女性中)以及生命早期的能量限制与具有IGFBP甲基化特征的结直肠肿瘤风险相关。
体型可能特别会增加IGFBP基因甲基化的结直肠肿瘤的风险;这一发现可能有助于采取更具针对性的方法来预防与肥胖相关的结直肠癌。